Effects of intra-articular hyaluronic acid and corticosteroid therapies on articular cartilage in experimental severe osteoarthritis [3]

Clinical and Experimental Rheumatology

Volumn 24, Issue 6, 2006, Pages 724-

  Eyigor, Sibel ^a   Hepguler, S ^a   Sezak, M ^a   Oztop F ^a   Capaci, K ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYALURONIC ACID; METHYLPREDNISOLONE; PAPAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HISTOPATHOLOGY; KNEE OSTEOARTHRITIS; LETTER; NONHUMAN; PRIORITY JOURNAL; RABBIT; RANDOMIZATION; STATISTICAL SIGNIFICANCE; SYNOVIUM; TISSUE REGENERATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; METHYLPREDNISOLONE; OSTEOARTHRITIS; RABBITS;

EID: 33846446709     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (11)

1. ROBION FC, DOIZE B, BOURE L et al.: Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated infra-articular administration of methylprednisolone acetate on articular cartilage in vivo. J Orthop Res 2001; 19: 250-8.
2. PELLETIER JP, MINEAU F, RAYNAULD JP, WOESSNER JF, SMITH ZG, PELLETIER JM: Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in paralel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 1994; 37: 414-23.
3. TAKAHASHI K, GOOMER RS, HARWOOD F, KUBO T, HIRASAWA Y, AMIEL D: The effects of hyaluronan on matrix metalloproteinase-3, interleukin -1 beta and tissue inhibitor of metalloproteinase-1 gene expression during the development of osteoarthritis. Osteoarthritis Cart 1999; 7: 182-190.
4. TAMIR E, ROBINSON D, KOREN R, AGAR G, HALPERIN N: Infra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: A randomized, double blind, placebo controlled study. Clin Exp Rheumatol 2001; 19: 265-70.
5. KAWANO T, MIURA H, MAWATARI T et al.: Mechanical effects of the intraarticular administration of high molecular weight hyaluronic acid plus phospholipid on synovial joint lubrication and prevention of articular cartilage degeneration in experimental osteoarthritis. Arthritis Rheum 2003; 48: 1923-9.
6. KARATOSUN V, UNVER B, GOCEN Z, SEN A: Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee. A prospective, randomized, double-blind study with long term follow-up. Clin Exp Rheumatol 2005; 23: 213-8.
7. TAKAHASHI K, HASHIMOTO S, KUBO T, HIRASAWA Y, LOTZ M, AMIEL D: Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 2000; 27: 1713-20.
8. BRANDT KD, SMITH GN, MYERS SL: Hyaluronan injection affects neither osteoarthritis progression nor loading of the OA knee in dogs. Biorheology 2004; 41: 493-502.
9. RONCHETTI P, GUERRA D, TAPARELLI F et al.: Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology (Oxford) 2001; 40: 158-69.
10. CABORN D, RUSH J, LANZER W, PARENTI D, MURRAY C: Synvisc 901 study group. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol 2004; 31: 333-43.
11. TASCIOGLU F, ÖNER C: Efficacy of infra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin Rheumatol 2003; 22: 112-7.